Antifungal activity of decyl gallate against several species of pathogenic fungi

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  De Paula E Silva, Ana Carolina Alves ^a   Costa Orlandi, Caroline Barcelos ^a   Gullo, Fernanda Patrícia ^a   Sangalli Leite, Fernanda ^a   De Oliveira, Haroldo Cesar ^a   Silva, Julhiany De Fátima Da ^a   Scorzoni, Liliana ^a   Pitangui, Nayla De Souza ^a   Rossi, Suélen Andrea ^a   Benaducci, Tatiane ^a   Wolf, Vanessa Gonçalves ^a   Regasini, Luis Octávio ^a   Petrônio, Maicon Segalla ^a   Silva, Dulce Helena Siqueira ^a   Bolzani, Vanderlan S ^a   Fusco Almeida, Ana Marisa ^a   Mendes Giannini, Maria José Soares ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIC ACID;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CELL VIABILITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; CRYPTOCOCCUS; CYTOTOXICITY TEST; DRUG SELECTIVITY; DRUG STRUCTURE; HISTOPLASMA CAPSULATUM; IC50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARACOCCIDIOIDES;

EID: 84914693472     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/506273     Document Type: Article

References (35)

1. Ostrosky-Zeichner L., Invasive mycoses: diagnostic challenges. American Journal of Medicine 2012 125 1 S14 S24 10.1016/j.amjmed.2011.10.008 2-s2.0-84055193579
2. Pfaller M. A., Diekema D. J., Epidemiology of invasive mycoses in North America. Critical Reviews in Microbiology 2010 36 1 1 53 10.3109/10408410903241444 2-s2.0-74949107171
3. Miceli M. H., Díaz J. A., Lee S. A., Emerging opportunistic yeast infections. The Lancet Infectious Diseases 2011 11 2 142 151 10.1016/S1473-3099(10)70218-8 2-s2.0-78751683832
4. Martín-Peña A., Aguilar-Guisado M., Cisneros J. M., Does the current treatment of invasive fungal infection need to be reviewed? Enfermedades Infecciosas y Microbiología Clínica 2014 32 8 523 528 10.1016/j.eimc.2013.02.008 2-s2.0-84875927652
5. Chen S. C. A., Playford E. G., Sorrell T. C., Antifungal therapy in invasive fungal infections. Current Opinion in Pharmacology 2010 10 5 522 530 10.1016/j.coph.2010.06.002 2-s2.0-77956647847
6. Leal P. C., Mascarello A., Derita M., Zuljan F., Nunes R. J., Zacchino S., Yunes R. A., Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi. Bioorganic & Medicinal Chemistry Letters 2009 19 6 1793 1796 10.1016/j.bmcl.2009.01.061 2-s2.0-61349117570
7. Locatelli C., Filippin-Monteiro F. B., Creczynski-Pasa T. B., Alkyl esters of gallic acid as anticancer agents: a review. European Journal of Medicinal Chemistry 2013 60 233 239 10.1016/j.ejmech.2012.10.056 2-s2.0-84871714485
8. Kubo I., Xiao P., Nihei K.-I., Fujita K.-I., Yamagiwa Y., Kamikawa T., Molecular design of antifungal agents. Journal of Agricultural and Food Chemistry 2002 50 14 3992 3998 10.1021/jf020088v 2-s2.0-0037014297
9. Kubo I., Masuoka N., Ha T. J., Shimizu K., Nihei K.-I., Multifunctional antioxidant activities of alkyl gallates. The Open Bioactive Compounds Journal 2010 3 1 11 10.2174/1874847301003010001 2-s2.0-77953455602
10. M27-A3, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard 2008 3rd Wayne, Pa, USA Clinical and Laboratory Standards Intitute
11. de Paula e Silva A. C., Oliveira H. C., Silva J. F., Sangalli-Leite F., Scorzoni L., Fusco-Almeida A. M., Mendes-Giannini M. J. S., Microplate alamarblue assay for paracoccidioides susceptibility testing. Journal of Clinical Microbiology 2013 51 4 1250 1252 10.1128/JCM.02914-12 2-s2.0-84875846563
12. M38-A2, Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard-second edition. Clinical and Laboratory Standards Institute (CLSI) 2008 Wayne, Pa, USA Clinical and Laboratory Standards Intitute
13. Regasini L. O., Pivatto M., Scorzoni L., Benaducci T., Fusco-Almeida A. M., Giannini M. J. S. M., Barreiro E. J., Siva D. H. S., Bolzani V. D. S., Antimicrobial activity of Pterogyne nitens Tul., Fabaceae, against opportunistic fungi. Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy 2010 20 5 706 711 10.1590/S0102-695X2010005000017 2-s2.0-78650409347
14. Gullo F. P., Sardi J. C. O., Santos V. A. F. F. M., Sangalli-Leite F., Pitangui N. S., Rossi S. A., De Paula E Silva A. C. A., Soares L. A., Silva J. F., Oliveira H. C., Furlan M., Silva D. H. S., Bolzani V. S., Mendes-Giannini M. J. S., Fusco-Almeida A. M., Antifungal activity of maytenin and pristimerin. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 340787 10.1155/2012/340787 2-s2.0-84862288163
15. Morais M. C. C., Luqman S., Kondratyuk T. P., Petronio M. S., Regasini L. O., Silva D. H. S., Bolzani V. S., Soares C. P., Pezzuto J. M., Suppression of TNF- α induced NF B activity by gallic acid and its semi-synthetic esters: possible role in cancer chemoprevention. Natural Product Research 2010 24 18 1758 1765 2-s2.0-78149264709 10.1080/14786410903335232
16. Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983 65 1-2 55 63 10.1016/0022-1759(83)90303-4 2-s2.0-0021061819
17. Adamu M., Naidoo V., Eloff J. N., Some Southern African plant species used to treat helminth infections in ethnoveterinary medicine have excellent antifungal activities. BMC Complementary and Alternative Medicine 2012 12, article 213 10.1186/1472-6882-12-213 2-s2.0-84868311622
18. Villar R., Vicente E., Solano B., Pérez-Silanes S., Aldana I., Maddry J. A., Lenaerts A. J., Franzblau S. G., Cho S.-H., Monge A., Goldman R. C., In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide. Journal of Antimicrobial Chemotherapy 2008 62 3 547 554 10.1093/jac/dkn214 2-s2.0-49649096677
19. Vicente E., Pérez-Silanes S., Lima L. M., Ancizu S., Burguete A., Solano B., Villar R., Aldana I., Monge A., Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides. Bioorganic and Medicinal Chemistry 2009 17 1 385 389 10.1016/j.bmc.2008.10.086 2-s2.0-57649196329
20. Savi L. A., Leal P. C., Vieira T. O., Evaluation of anti-herpetic and antioxidant activities, and cytotoxic and genotoxic effects of synthetic alkyl-esters of gallic acid. Arzneimittel-Forschung 2005 55 1 66 75 2-s2.0-12944297113
21. Ito S., Nakagawa Y., Yazawa S., Sasaki Y., Yajima S., Antifungal activity of alkyl gallates against plant pathogenic fungi. Bioorganic and Medicinal Chemistry Letters 2014 24 7 1812 1814 10.1016/j.bmcl.2014.02.017 2-s2.0-84897450066
22. Silva I. C., Regasini L. O., Petrãnio M. S., Silva D. H. S., Bolzani V. S., Belasque J., Sacramento L. V. S., Ferreira H., Antibacterial activity of alkyl gallates against Xanthomonas citri subsp. citri. Journal of Bacteriology 2013 195 1 85 94 10.1128/JB.01442-12 2-s2.0-84872042524
23. Flausino O. A. Jr., Dufau L., Regasini L. O., Petrônio M. S., Silva D. H. S., Rose T., Bolzani V. S., Reboud-Ravaux M., Alkyl hydroxybenzoic acid derivatives that inhibit HIV-1 protease dimerization. Current Medicinal Chemistry 2012 19 26 4534 4540 10.2174/092986712803251557 2-s2.0-84868035469
24. Ximenes V. F., Lopes M. G., Petrônio M. S., Regasini L. O., Siqueira Silva D. H., da Fonseca L. M., Inhibitory effect of gallic acid and its esters on 2,2′-azobis(2- amidinopropane)hydrochloride (AAPH)-induced hemolysis and depletion of intracellular glutathione in erythrocytes. Journal of Agricultural and Food Chemistry 2010 58 9 5355 5362 10.1021/jf100233y 2-s2.0-77952117239
25. Maubon D., Garnaud C., Calandra T., Sanglard D., Cornet M., Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Medicine 2014 40 9 1241 1255 10.1007/s00134-014-3404-7
26. Sloan D. J., Parris V., Cryptococcal meningitis: epidemiology and therapeutic options. Clinical Epidemiology 2014 6 1 169 182 2-s2.0-84900559961 10.2147/CLEP.S38850
27. Buitrago M. J., Bernal-Martínez L., Castelli M. V., Rodríguez-Tudela J. L., Cuenca-Estrella M., Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis. Journal of Travel Medicine 2011 18 1 26 33 10.1111/j.1708-8305.2010.00477.x 2-s2.0-78650926693
28. Kubo I., Muroi H., Kubo A., Structural functions of antimicrobial long-chain alcohols and phenols. Bioorganic & Medicinal Chemistry 1995 3 7 873 880 2-s2.0-0029039587 10.1016/0968-0896(95)00081-Q
29. Fujita K., Kubo I., Plasma membrane injury induced by nonyl gallate in Saccharomyces cerevisiae. Journal of Applied Microbiology 2002 92 6 1035 1042 10.1046/j.1365-2672.2002.01614.x 2-s2.0-0036094198
30. Haworth R. S., Cragoe E. J. Jr., Fliegel L., Amiloride and 5-(N-ethyl-N-isopropyl)amiloride inhibit medium acidification and glucose metabolism by the fission yeast Schizosaccharomyces pombe. Biochimica et Biophysica Acta 1993 1145 2 266 272 10.1016/0005-2736(93)90298-E 2-s2.0-0027473929
31. Sangalli-Leite F., Scorzoni L., Mesa-Arango A. C., Casas C., Herrero E., Soares Mendes Gianinni M. J., Rodríguez-Tudela J. L., Cuenca-Estrella M., Zaragoza O., Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst. Microbes and Infection 2011 13 5 457 467 10.1016/j.micinf.2011.01.015 2-s2.0-79953278557
32. Albernaz L. C., de Paula J. E., Romero G. A. S., Silva M. D. R. R., Grellier P., Mambu L., Espindola L. S., Investigation of plant extracts in traditional medicine of the Brazilian Cerrado against protozoans and yeasts. Journal of Ethnopharmacology 2010 131 1 116 121 2-s2.0-77955334003 10.1016/j.jep.2010.06.011
33. Magalhães T. F. F., da Silva C. M., de Fátima Â., da Silva D. L., Modolo L. V., Martins C. V. B., Alves R. B., Ruiz A. L. T. G., Longato G. B., de Carvalho J. E., de Resende-Stoianoff M. A., Hydroxyaldimines as potent in vitro anticryptococcal agents. Letters in Applied Microbiology 2013 57 2 137 143 10.1111/lam.12086 2-s2.0-84880507463
34. Mistro S., MacIel I. D. M., de Menezes R. G., Maia Z. P., Schooley R. T., Badaró R., Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis. Clinical Infectious Diseases 2012 54 12 1774 1777 10.1093/cid/cis290 2-s2.0-84861525317
35. Ellis D., Amphotericin B: spectrum and resistance. Journal of Antimicrobial Chemotherapy 2002 49 1 7 10 2-s2.0-0036178410